Histone ModificationsChromatinChromatin RemodelingEpigenetic ChangeEpigenomicsPathologyCancer GenomicsEpigenetic DysregulationPotential BiomarkersSystems BiologyMedicineCell BiologyEpigeneticsTumor MicroenvironmentCancer Research
Epigenetic dysregulation is being increasingly recognized as a hallmark of cancer. Post-translational modifications of histones, in particular, are known to play important roles gene expression alterations in cancer development and progression. Given their key involvement in the various stages of carcinogenesis, histone modifications are also being explored as potential biomarkers of disease progression and prognosis. This review will therefore discuss the role of histone modifications in cancer biology and will explore their prognostic potential.
40
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Karolin Luger, Armin W. Mäder, Robin K. Richmond et al. · Nature · 1997 · 9.3K citations
Nucleosome Core Particle, Crystal Structure, Engineering +10
The polycomb group protein EZH2 is involved in progression of prostate cancer
Sooryanarayana Varambally, Saravana M. Dhanasekaran, Ming Zhou et al. · Nature · 2002 · 2.7K citations · Full text